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Background: Acute myocarditis can be diagnosed on cardiovascular magnetic resonance (CMR) using multiple
techniques, including late gadolinium enhancement (LGE) imaging, which requires contrast administration. Native
T1-mapping is significantly more sensitive than LGE and conventional T2-weighted (T2W) imaging in detecting
myocarditis. The aims of this study were to demonstrate how to display the non-ischemic patterns of injury and to
quantify myocardial involvement in acute myocarditis without the need for contrast agents, using topographic
T1-maps and incremental T1 thresholds.
Methods: We studied 60 patients with suspected acute myocarditis (median 3 days from presentation) and 50
controls using CMR (1.5 T), including: (1) dark-blood T2W imaging; >(2) native T1-mapping (ShMOLLI); (3) LGE.
Analysis included: (1) global myocardial T2 signal intensity (SI) ratio compared to skeletal muscle; (2) myocardial
T1 times; (3) areas of injury by T2W, T1-mapping and LGE.
Results: Compared to controls, patients had more edema (global myocardial T2 SI ratio 1.71 ± 0.27 vs.1.56 ± 0.15),
higher mean myocardial T1 (1011 ± 64 ms vs. 946 ± 23 ms) and more areas of injury as detected by T2W (median
5% vs. 0%), T1 (median 32% vs. 0.7%) and LGE (median 11% vs. 0%); all p < 0.001. A threshold of T1 > 990 ms
(sensitivity 90%, specificity 88%) detected significantly larger areas of involvement than T2W and LGE imaging in
patients, and additional areas of injury when T2W and LGE were negative. T1-mapping significantly improved the
diagnostic confidence in an additional 30% of cases when at least one of the conventional methods (T2W, LGE)
failed to identify any areas of abnormality. Using incremental thresholds, T1-mapping can display the non-ischemic
patterns of injury typical of myocarditis.
Conclusion: Native T1-mapping can display the typical non-ischemic patterns in acute myocarditis, similar to LGE
imaging but without the need for contrast agents. In addition, T1-mapping offers significant incremental diagnostic
value, detecting additional areas of myocardial involvement beyond T2W and LGE imaging and identified extra
cases when these conventional methods failed to identify abnormalities. In the future, it may be possible to perform
gadolinium-free CMR using cine and T1-mapping for tissue characterization and may be particularly useful for
patients in whom gadolinium contrast is contraindicated.
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Acute myocarditis can be detected using cardiovascular mag-
netic resonance (CMR) using multiple tissue characterization
techniques, especially T2-weighted (T2W) imaging for
edema and late gadolinium enhancement (LGE) [1-3].
LGE is especially powerful in generating excellent con-
trast between diseased and normal myocardium, allow-
ing visualization of LGE patterns and distribution to
differentiate between ischemic and non-ischemic etiolo-
gies of myocardial disease [4,5].
However, there are some limitations in using LGE
alone in the diagnosis of acute myocarditis. Very small
areas of myocarditis may not always be detected. Some
patients demonstrate predominant global edema rather
than frank myocyte necrosis, resulting in negative find-
ings on LGE imaging [1]. Diffuse myocarditis may not
be objectively detectable given that the image analysis
of LGE requires normal myocardium as a reference re-
gion of interest (ROI) for comparison. Additionally,
although the risk is low, gadolinium-based contrast
agents are associated with the rare but serious compli-
cation of nephrogenic systemic fibrosis in patients with
significant renal impairment [6]. Thus, it would be use-
ful if there were a method which is sensitive to display-
ing the different changes in myocarditis without the
need for exogenous contrast agents.
Native (or pre-contrast) T1-mapping directly esti-
mates the T1 (proton spin–lattice) relaxation time of
tissues on a pixel-by-pixel basis. Native myocardial T1
values have recently been validated in a large, multicen-
tre normal cohort study to have a tight normal range
[7], and shown to be superior to T2-weighted imaging
in detecting edema [8] as well as acute myocarditis [9].
Further, native T1-mapping has an equivalent diagnos-
tic performance to LGE in diagnosing myocarditis,
with a superior sensitivity (90%) to both T2W and
LGE imaging [9]. In addition to providing a single nu-
meric average myocardial T1 value for a subject, T1-
maps should be fully utilized for visual and spatial
characterization of changes in the left ventricular
myocardium.
In this study, the hypothesis is two-fold: (1) given that
T1-mapping is highly sensitive compared to conven-
tional CMR techniques in detecting changes in myocar-
ditis [9], we propose that it should be able to directly
locate the areas of myocardial involvement on a pixel-
wise basis, including additional areas of injury; (2) T1-
mapping may be able to detect the non-ischemic pat-
terns of injury typically seen on LGE images as areas
with higher T1 values compared to the rest of the myo-
cardium. We demonstrate novel approaches for visual-
izing the extent and patterns of myocardial injury in
acute myocarditis using topographic T1-maps and in-
cremental T1 thresholds.Methods
Characteristics of the study population
This was a prospective study including 60 consecutive pa-
tients (age 41 ± 16 years; 25% female) presenting with sus-
pected acute myocarditis [1] as inpatients to two hospitals
(The John Radcliffe Hospital and Milton Keynes Hospital,
United Kingdom) [9]. Patients underwent CMR scanning
at the John Radcliffe Hospital within fourteen days (median
3 days, interquartile range IQR 1–6 days) of presentation
between January 2010 and March 2013. In a previously
published study, we demonstrated the superior sensitivity
of native T1-mapping to T2W and LGE imaging in detect-
ing acute myocarditis [9]. The cumulative CMR data de-
rived from this study and new patient material were
utilized for the present analysis to generate topographic
and incremental threshold T1-maps. All patients had: (a)
acute chest pain; (b) elevation in cardiac troponin I level >
0.04 μg/L (median 4.50 μg/L, IQR 0.89-14.98 μg/L); (c) his-
tory of recent systemic viral or inflammatory illness (93%,
n = 56/60), or absence of significant (>50%) obstructive
coronary artery disease (CAD) on coronary angiography
(70%, n = 42/60); coronary angiography was not per-
formed in the remaining patients (n = 18) due to young
age <35 years (n = 14), no known risk factors for CAD
(n = 2) or a convincing history of a viral/inflammatory
etiology (n = 2). Exclusion criteria included contraindi-
cations to CMR, previous myocardial infarction, previ-
ous myocarditis or any chronic cardiac conditions.
Patients who demonstrated myocardial infarction as ev-
idenced by an ischemic pattern of LGE (i.e. an isolated
area involving the subendocardium) or an obvious alter-
native diagnosis on CMR (such as Takotsubo or hyper-
trophic cardiomyopathy) were also excluded. Healthy
volunteers (n = 50) of similar age and gender distribution
(age 41 ± 13 years; 26% female) with no cardiac history or
known cardiac risk factors, not on cardiovascular medica-
tions and with a normal electrocardiogram underwent
CMR as controls. Ethical approval was granted for all
study procedures and all subjects gave written informed
consent.
Cardiovascular magnetic resonance
CMR studies were performed on a single 1.5 Tesla MR
system (Avanto, Siemens Healthcare, Germany) using a
32-channel phased-array coil, except for short-tau inver-
sion recovery (STIR) imaging for which the body coil
was used, as previously published [9]. Briefly, cine im-
ages were obtained in three long-axis views, and in the
short-axis plane covering the base to apex of the heart.
Tissue characterization covering the left ventricle from
base to apex was performed for T2W, T1-mapping and
LGE imaging in matching short-axis slices. Dark-blood
T2-weighted imaging for edema was performed using
the STIR sequence [1,10] and T1-mapping using the
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(ShMOLLI) sequence [11], before administration of con-
trast agents. LGE imaging was acquired in the long and
short-axis planes using a T1-weighted phase-sensitive inver-
sion recovery (PSIR) sequence [12] 8–12 minutes after
intravenous administration of contrast agent (Gadodiamide,
Omniscan, GE Healthcare, total 0.13 mmol/kg). Typical im-
aging parameters were as previously published [8,9] (see
Additional file 1).
Image analysis
Image analysis of left ventricular ejection fraction was
performed using Argus software (Siemens Medical Solu-
tions) on cine images. Analysis of short axis images from
T1-mapping, T2W and LGE imaging was performed as
previously published [8,9]. Briefly, on dark-blood T2W
images, edema is diagnosed when myocardial T2 SI ratio
is ≥2:1 compared to that of skeletal muscle or when
myocardial T2 SI is ≥2.0 standard deviations above the
mean SI of remote tissue in the same slice [1]. Remote
myocardium in acute myocarditis may be challenging to
identify as the process may be global; thus a region of
the myocardium with no obvious visual increase in rela-
tive T2 SI and no LGE was chosen to represent myocar-
dium least affected by the disease process, taking care to
also avoid regions with abnormally low signal. Results of
T1-mapping were based on quantitative analysis of all T1-
maps (rather than visualization of color maps). Care was
taken when placing the endo- and epicardial contours to
avoid contamination by blood-pool and extra-myocardial
structures to minimize the partial volume effect on myo-
cardial T1 values [7]. Acute myocardial injury is diagnosed
when T1 is > 990 ms, as previously published for the ob-
jective detection of acute myocardial edema [8]. Focal
areas of LGE were defined as those with a SI ≥2.0 standard
deviations above the mean SI of remote myocardium. In
addition to using T1 > 990 ms to generate topographic
maps to delineate the location and extent of myocardial
involvement, we also used a set of higher, incremental T1
thresholds to detect and describe the visual pattern of le-
sions based on their T1 elevation. For all analyses, only
myocardial regions with a contiguous area of ≥ 40 mm2
above the specified thresholds were considered abnormal
[9]; this corresponds to 10 adjacent pixels for the STIR
method, in accordance with currently proposed recom-
mendations [1] to reduce the detection of noise as positive
findings. To calculate the extent of myocardial injury in a
subject detected by the tissue characterization techniques,
the percentage of abnormal myocardium as defined above
was determined for each segment and then averaged for
that subject. In addition to quantitative image analyses,
qualitative visual analysis for T2W and LGE images were
performed by at least 2 expert CMR cardiologists; any dif-
ference in opinion was resolved by presenting the case toat least one additional expert CMR cardiologist before
reaching a final interpretation.CMR image quality assessment
Each LV myocardial segment was strictly assessed for
image quality before inclusion into the final analyses and
only segments with no or minimal artifacts were included, as
previously published [8]. On cine imaging, 3% of segments
corresponding to the LVOT were rejected; on dark-blood
T2W imaging, 9% were rejected due to artifacts, signal
dropout or breathing motion; T1-maps were assessed for
quality in three ways: examination of the T1-map, the
raw T1 images and R2 maps; 11% of the segments were
excluded due to off-resonance artifacts, partial volume ef-
fect, poor T1 fit on the R2 maps, patient movement or low
SNR; on LGE imaging, 3% were rejected due to artifacts
caused by patient movement or poor image quality. To
avoid bias towards or against any single technique, main
analyses were repeated with all artifacts re-included and
results provided in the main text or Additional file 1.Statistical analysis
Normality of data was tested using the Kolmogorov-
Smirnov test. Normally distributed data are presented as
mean ± standard deviation (SD); non-parametric data are
presented as median with interquartile range (IQR). Un-
paired samples between groups were assessed by the un-
paired 2-tailed Student’s t-test, or the Mann–Whitney U
test for non-parametric data. Any segmental analysis was
averaged on a per-subject basis before any inter-individual
and group comparisons to control for clustering of seg-
ments within each subject. All statistical tests were two-
tailed, with p-values of less than 0.05 considered statisti-
cally significant. To determine the presence of significant
differences in subject groups when using multiple CMR
methodologies, ANOVA analysis was performed with
Bonferroni corrected post-hoc comparisons for parametric
data; for non-parametric data, the Kruskal-Wallis one-way
analysis of variance was performed with post-hoc pairwise
comparisons. For comparisons of the extent of myocardial
injury measured by multiple CMR methodologies within
the same patient subgroup, the Friedman test was used for
non-parametric data with post-hoc comparisons. Receiver
operator characteristic (ROC) analysis was performed to
compare the diagnostic performance of the CMR methods
in detecting myocardial changes in patients compared to
controls. Significance of ROC analyses was assessed using
the method of Delong et al. [13]. The McNemar test and
Cochran’s Q-test were used for comparing combinations
of CMR tissue criteria in the diagnosis of acute myocardi-
tis. Statistical analyses were performed using MedCalc
(version11.5.1.0, MedCalc Software, Mariakerke, Belgium).
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CMR findings in acute myocarditis
An example of whole-heart multiparametric tissue
characterization is shown in Figure 1. CMR findings are
presented in Table 1. Compared to controls, patients had
a significantly lower mean LV ejection fraction (EF), higher
global myocardial T2 SI ratio, mean myocardial T1 values
and larger areas of myocardial injury measured by T2, T1
and LGE. The pattern of LGE, when each is considered in
isolation, was predominantly subepicardial (96%) and mid-
wall (84%), localized most frequently to the lateral wall
(98%) and inferior wall (96%), typical for myocarditis.
None of the 60 patients demonstrated an isolated ischemic
(subendocardial) pattern of LGE to suggest myocardial in-
farction as the etiology of the acute presentation.
Receiver operator characteristics (ROC) analysis compar-
ing diagnostic performance of the techniques showed that
T1-mapping and LGE (with area-under-the-curve AUC of
0.94 and 0.93, respectively; p = ns) were significantly super-
ior to dark-blood T2W imaging in the detection of acute
myocarditis (AUC 0.76; p < 0.05 for both). Repeat analysis
including all image artifacts showed preservation of all rela-
tive relationships and statistical significance (AUC of 0.92,
0.94 and 0.75, respectively). These results are closely com-
parable to our previous results using the same techniques
in patients with suspected acute myocarditis [9]. The diag-
nostic performance of all individual and combination tissue
criteria is presented in Table 2.Figure 1 Whole-heart multiparametric cardiovascular magnetic reson
(Left to right) Short-axis slices covering the left ventricle from base to apexIncremental value of T1-mapping in the detection of myo-
cardial injury in acute myocarditis
In order to assess whether T1-mapping offers any incre-
mental value over conventional CMR techniques (T2W,
LGE) in the detection of myocarditis, patients were further
stratified into subgroups according to their diagnostic cer-
tainty based on edema (T2W) and LGE imaging as used
in typical clinical settings (Figure 2). CMR findings and
patient characteristics in each subgroup are presented in
Tables 1 and 3.
Group I patients (edema+, LGE+) demonstrated both
edema and LGE patterns typical of myocarditis. They
had more severe myocardial injury, as evidenced by a
significantly higher Troponin I level and lower EF than
other patient subgroups and controls (all p < 0.05).
Group I patients also had significantly more edema and
LGE compared to controls and other patient subgroups
(all p < 0.05).
Group II patients (edema- LGE+) did not fulfill criteria
for edema but demonstrated typical LGE patterns. Rea-
sons included not meeting current T2 SI cut-off values for
edema despite good image quality (n = 8), and non-
diagnostic image quality due to poor breath-holding (n =
2) or tachyarrhythmia (n = 2). These patients suffered less
severe myocardial injury, with a significantly lower median
Troponin I level, smaller areas of LGE than Group I pa-
tients (all p < 0.05) and a mean EF no different from
controls.ance (CMR) tissue characterization in acute myocarditis.
.
Table 1 Tissue characteristics in controls and patient groups
CMR findings Controls
(n = 50)
All patients
(n = 60)
Group I
(Edema+, LGE+) (n = 41)
Group II
(Edema-, LGE+) (n = 12)
Group III
(Edema-, LGE-) (n = 7)
Ejection fraction (%) 72 ± 6 64 ± 12* 61 ± 13† 70 ± 11 72 ± 6
Global myocardial T2 SI ratio‡ 1.56 ± 0.15 1.71 ± 0.27* 1.79 ± 0.27† 1.60 ± 0.16 1.47 ± 0.17
Myocardial injury by
T2 SI ratio≥ 2.0 (%)
0 (0 to 2) 5 (1 to 18)* 9 (3 to 22)† 0.6 (0 to 4) 0 (0 to 0)
Mean myocardial T1 (ms) 946 ± 23 1011 ± 64* 1030 ± 62† 986 ± 54† 947 ± 27
Myocardial injury by
T1≥ 990 ms (%)
0.7 (0 to 3) 32 (15 to 65)* 49 (24 to 70)† 15 (12 to 29)† 6 (2 to 7)†
Myocardial injury
by LGE (%)§
0 (0 to 1) (n = 35) 11 (4 to 20)* 16 (8 to 24)† 7 (4 to 12)† 1 (0 to 2)
Values are presented as mean ± SD or median (interquartile range). *p < 0.001 when compared to controls.
In post-hoc subgroup analyses: †significantly different from controls;
areas of injury by T2 (edema) were significantly larger in Group I than Group II and III;
areas of injury by both T1 and LGE were significantly larger in Group I > II > III patients.
‡Global myocardial T2 SI ratio = T2 SI myocardium: sk. muscle
§LGE is detected when myocardial SI is ≥ 2.0 standard deviation above the mean SI of remote myocardium.
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strate edema or LGE on CMR. Three patients with diffi-
culty breath-holding had non-diagnostic dark-blood
T2W and LGE (including single shot LGE) imaging,
while the rest did not demonstrate findings despite good
image quality. These patients had a very low median
Troponin I level (0.48 μg/L) and a mean EF no different
from controls.
T1-mapping, using a threshold of T1 ≥ 990 ms [8], was
able to detect a significantly larger extent of myocardial
injury compared to T2 and LGE imaging in all patient
subgroups and compared to controls (all p < 0.05; Table 1Table 2 Diagnostic performance of CMR tissue characterization
Tissue criteria Sensitivity (%)
Individual
T1-mapping* 90
Dark-blood T2* 48
LGE 72
Combination (with LGE)
Dark-blood T2 and LGE (2 out of 2)†‡ 45
Dark-blood T2 or LGE (Any 1 of 2) 75
T1-mapping and LGE (2 out of 2)† 67
T1-mapping or LGE (Any 1 of 2) 95
T1-mapping, dark-blood T2 or LGE (Any 1 of 3) 95
T1-mapping, dark-blood T2 or LGE (Any 2 of 3) 70
T1-mapping and dark-blood T2 and LGE (3 out of 3) 45
Combination (without LGE)
T1-mapping and dark-blood T2 (2 out of 2)‡ 48
T1-mapping or dark-blood T2 (Any 1 of 2) 90
*statistically different (p < 0.05); †‡no statistical difference (p = ns). T1-mapping: myo
imaging: edema is diagnosed when the T2 SI ratio (T2 SI myocardium : skeletal muscle) is
2 SD above mean SI of remote myocardium. For each technique, only contiguous a
relevant; involvement of ≥5% of any segment on a per-subject basis was the thresh
negative predictive value.and Figure 3). These findings demonstrate more global
involvement in myocarditis than conventional methods
(T2W, LGE) show. In Group II (edema-, LGE+) patients,
T1-mapping was able to detect areas of acute injury in
all 12 out of 12 cases, representing an additional 20% of
cases when dark-blood T2-weighted imaging did not
provide a diagnosis of edema, improving the PPV from
the original 90% (based on the “T2 or LGE” combination
representative of Group II; Table 2) to 98% (based on
the “T1 and LGE” combination for the 4 patients with
non-diagnostic dark-blood T2 images) and also 98% for
the 8 patients with good quality dark-blood T2 imagesmethods in the detection of suspected acute myocarditis
Specificity (%) Accuracy (%) PPV (%) NPV (%)
88 89 90 88
86 66 81 58
97 81 98 67
97 64 96 51
86 79 90 67
97 78 98 63
83 91 91 91
71 86 85 89
97 80 98 65
97 64 96 51
98 71 97 61
76 84 82 86
cardial injury is detected when T1 is ≥ 990 ms; Dark-blood T2-weighted
≥ 2:1; Late gadolinium enhancement (LGE) is detected when myocardial SI is ≥
reas of myocardium ≥40 mm2 above the stated threshold were considered
old used for comparison of methods. PPV = positive predictive value; NPV =
Figure 2 T1-maps detected the location and extent of myocardial injury in acute myocarditis. Areas of myocardial injury (red) as detected
by computer-aided analysis of T1-maps, T2-weighted and late gadolinium enhanced (LGE) images in a normal subject (row 1) and patients with
acute myocarditis (rows 2–4). Red indicates areas of myocardium with values above the stated threshold for each method. Green contour marks
the position of reference region of interest (ROI). Skeletal muscle ROI for T2W images not shown. Note that a T1 cut-off of ≥ 990 ms detected
larger areas of injury than corresponding T2W and LGE imaging analysis.
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or LGE” combination). Further, in Group III (edema-,
LGE-) patients, T1-mapping was able to detect small
focal areas of injury in 6 of the 7 cases (an additional
10% of the cohort), in at least 2 contiguous slices or 2
orthogonal planes, and not due to artifacts or poor T1
fit (Figure 4). This improved the diagnostic confidence
in Group III from the previous NPV of 51% for ruling
out myocarditis (based on negative findings on T2 and
LGE) to now a PPV of 90% for the 3 patients with sub-
optimal images (based on the use of T1-mapping as a
single criterion) or 85% for the patients with good T2W
and LGE images (now based on the “Any 1 of 3: T1-Table 3 Baseline characteristics of patient subgroups compar
Normal volunteers
(n = 50)
Grou
(Edema+
Age (years) 41 ± 13
Female, n (%) 13 (26)
Troponin I (μg/L) n/a 9.60 (3
Coronary angiogram performed, n (%) n/a
Median (IQR) time from symptoms
to CMR (days)
n/a 2
Values are mean ± SD, n (%), or median (interquartile range). *significantly different
characteristics amongst subgroups.mapping, T2 or LGE” combination). Overall, T1-mapping
significantly improved the diagnostic confidence in an
additional 30% of cases when at least one of the conven-
tional methods (T2W, LGE) failed to identify any areas of
abnormality.
Ability of native T1-mapping to display the patterns and
distribution of myocardial injury
Further information on tissue characterization may be ex-
tracted from native T1-maps using incremental thresholds
(Figure 5; selected T1 thresholds shown for illustrative pur-
poses). These revealed the underlying pattern of myocardial
injury, similar to that typically seen on LGE imaging.ed to normal controls
p I patients
, LGE+) (n = 41)
Group II patients
(Edema-, LGE+) (n = 12)
Group III patients
(Edema-, LGE-) (n = 7)
37 ± 12 46 ± 12 52 ± 13
68 (20) 4 (33) 3 (43)
.40 to 21.00)* 0.54 (0.25 to 4.19) 0.48 (0.19 to 1.29)
25 (61) 10 (83) 7 (100)*
(1 to 5) 3 (2 to 7) 3 (2 to 5)
from other patient subgroups; otherwise no statistical differences in
Figure 3 Extent of myocardial injury detected by T1-mapping, T2W and LGE imaging in acute myocarditis. T1-mapping detected a
significantly larger extent of myocardial injury in all patient subgroups compared to controls (all p < 0.0001), and compared to T2W and LGE
imaging within all patient subgroups (all p < 0.001). Bar graphs represent the median extent of injury within segments per subject; error bars
mark the interquartile range.
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T1 ≥ 990 ms revealed global myocardial injury; however,
using incremental thresholds, it became evident that the
areas with the highest T1 values were localized to the
lateral wall in a midwall or subepicardial pattern, similar
to the areas enhancing on LGE images. This is consist-
ent with the finding that patient segments with LGE had
significantly higher T1 values (1042 ± 66 ms), and pa-
tient segments without LGE (from Groups I-III) had less
elevated T1 values but still >2SD above normal (993 ±
56 ms vs. 946 ± 23 ms in controls; all p < 0.0001), sug-
gesting that areas without apparent LGE were also in-
volved. On the other hand, in cases of low-grade
myocarditis with low troponin levels (Figure 5, bottom
row); while using a high T1 threshold (e.g. 1200 ms)
would not have detected the changes, the threshold of
T1 ≥ 990 ms allowed immediate visualization of the area
of abnormality to the inferolateral wall in a predomin-
antly subepicardial or midwall pattern.
Thus, having a range of T1 thresholds (starting at
990 ms) allows the simultaneous quantification of myocar-
dial involvement as well as visualization of the topography
of injury within the affected myocardium, providing im-
portant information such as the presence of a non-ischemic
pattern of injury.
Discussion
In this work, we have shown for the first time that, in
acute myocarditis, whole-heart T1-mapping: (1) candiagnose extra cases with small areas of focal injury not
detected by T2W and LGE imaging; (2) detects a larger
extent of myocardial involvement than T2W and LGE
methods without increasing the number of false positive
findings, and; (3) can demonstrate patterns of non-
ischemic injury similar to LGE imaging, without the
need for exogenous contrast agents.
Insights from T1 characterization of acute myocarditis
Consistent with the current understanding of acute
myocarditis, the findings of significantly increased T2 SI
and T1 times in these patients support the notion that
edema and inflammation are major components in the
acute pathophysiologic process [1,14]. While acute
edema is known to increase native T1 relaxation times
[8,15], there may be additional changes, such as the dis-
tribution of free water fractions in the intra- and extra-
cellular compartments, that are more readily detected by
T1-mapping [15] than T2W methods. ShMOLLI T1-
mapping is more sensitive to disease (SN 90%, SP 88%)
compared to T2W (SN 48%, SP 86%) and LGE (SN 72%,
SP 97%) imaging using the stated thresholds, with still
very good specificity [9]; this may be attributed to its
tight normal range with low variability [7] and additional
sensitivity to disease due to magnetization transfer ef-
fects [16], which make it an excellent imaging bio-
marker. The results from this study demonstrated that
the higher sensitivity of T1-mapping did not result in
significantly more false positive findings in normal
Figure 4 T1-mapping located small areas of myocardial injury (red) when T2W and LGE imaging were negative. This figure shows
computer-aided analyses of CMR images from three representative cases of Group III patients (edema-, LGE-) with small rises in Troponin I.
T1-mapping detected small focal areas of injury in 6 out of the 7 patients in this group, in at least 2 contiguous short-axis slices or 2 orthogonal
planes that were not due to artifacts or poor T1 fit. Green contour marks the positioning of reference region of interest (ROI). Skeletal muscle ROI
for T2W images not shown.
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directly quantifies myocardial changes without the need
for reference ROIs may explain why T1-mapping was
able to detect larger areas of myocardial involvement
than T2W and LGE imaging.Figure 5 T1-maps using incremental thresholds demonstrate the pred
acute myocarditis. Red indicates areas of myocardium with a T1 value abov
threshold of 990 ms was previously validated for the detection of acute myocAs a method for imaging edema, T1-mapping may re-
place dark-blood T2 with statistically better diagnostic
performance in detecting changes of acute myocarditis as
a single criterion (T1-mapping vs. Dark-blood T2; p <
0.05; Table 2), or in combination with LGE (T1-mappingominantly non-ischemic pattern of injury across a spectrum of
e the stated threshold of at least 40 mm2 in contiguous area. T1
ardial edema; other thresholds were selected for illustrative purposes.
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mapping and LGE” demonstrating superior or equal nu-
merical results on all diagnostic parameters of SN, SP,
Accuracy, PPV, NPV). ShMOLLI T1-mapping can be par-
ticularly useful when conventional dark-blood T2W im-
aging fails (either due to tachyarrhythmia, the patient’s
inability to perform long breath-holds, the technique not
sensitive enough, or skeletal muscle inflammation).
We present for the first time how T1-mapping per-
mits quantification of the extent of myocardial involve-
ment as well as visualization of non-ischemic patterns
of injury in myocarditis. In many cases, a T1 threshold
of ≥ 990 ms [8] demonstrated that acute myocarditis is a
global process, within which there are focal areas of
even higher T1 values. These areas are characterized by
a predominantly subepicardial/midwall pattern or focal
islands of high T1 within the myocardium, typically in
the lateral or inferior wall. These observations are con-
sistent with previous work which demonstrated that
acute myocarditis starts as a focal process which then
spreads globally [17,18]. Once seeded within the myo-
cardium, it is possible that the wavefront of myocardial
injury spreads by direct extension away from the initial
focus (for example, in both a clockwise and counter-
clockwise direction on a slice), until the entire myocar-
dium is involved (Figure 5); this temporal pattern of in-
jury may be confirmed in future studies by performing
T1-mapping at serial time points within the first 14 days
of acute myocarditis, similar to the original study using
early gadolinium imaging which demonstrated this
process [17]. Even in some cases of severe myocarditis,
while an area may appear normal on LGE imaging
(Figure 5, top row), serial T1-maps starting at T1 ≥
990 ms revealed that the entire myocardium was in-
volved, only that the LGE-negative area had less ele-
vated T1 values. This is supported by the findings that,
while patient segments with LGE had significantly
higher T1 values, patient segments without LGE (from
Groups I, II and III) still demonstrated significantly
higher T1 values compared to controls (993 ± 56 vs.
946 ± 23 ms; p < 0.0001), suggesting that these areas were
also likely involved but perhaps to a milder degree and
presumably without significant necrosis. Further, very
small foci of myocarditis may be beyond the resolution of
LGE, and techniques such as T1-mapping may offer add-
itional advantage. For instance, the PSIR sequence for
LGE in this study offers a resolution of 2.0 × 1.5 ×
8.0 mm, whereas the resolution of the T1-map has a voxel
size of 0.9 × 0.9 × 8.0 mm based on the two-fold
interpolation of the IR-weighted images. Thus, T1-maps
with incremental thresholds not only can display the pre-
dominant non-ischemic pattern of myocarditis, but may
also provide additional insights such as the wavefronts
and truer extent of myocardial involvement.Clinical implications
T1-mapping with incremental thresholds revealing pat-
terns of myocardial injury has important clinical implica-
tions, as there is now a way to extract information similar
to LGE imaging without the need for exogenous contrast
agents. T1-mapping can effectively act as a method for
both edema and LGE pattern imaging. In the future, it
may be possible to perform a gadolinium-free CMR proto-
col using cine and T1-mapping, with T1-mapping as a sin-
gle criterion demonstrating around 90% in sensitivity,
specificity, accuracy, PPV and NPV. If greater specificity
and PPV were desired, an alternate approach could be to
combine T1-mapping with dark-blood T2W imaging
(refer to Table 2). If the patient fulfilled positive criteria
for both T1-mapping and dark-blood T2-weighted im-
aging (taking into account that the patterns and distribu-
tion of injury are consistent with myocarditis and not, for
example, an infarction), this has a PPV of 97% for acute
myocarditis, so one may argue that the patient needs no
administration of gadolinium for further LGE imaging,
since adding LGE with a subsequent positive finding (now
the “T1-mapping and Dark-blood T2 and LGE” combin-
ation criteria) has a PPV of 96%, which does not improve
the previous PPV of 97%. However, if “T1-mapping and
Dark-blood T2” were negative, this only has a NPV of 61%
for ruling out myocarditis, hence if the clinical suspicion
remains, gadolinium may be administered in attempt to
either obtain a possible diagnosis based on a third criter-
ion (now according to the “Any 1 of 3” combination in
Table 2) or to further rule out disease. In this case, if LGE
turns out to be positive in a pattern compatible with myo-
carditis, then the PPV is 85%. Such an approach should be
tested against other cardiac pathologies in a wide spectrum
of clinical presentation to further investigate the ability of
T1-mapping to distinguish diseases in combination with
other CMR techniques. It does hold promise for abbreviat-
ing CMR protocols and may be particularly useful for pa-
tients in whom gadolinium contrast is contraindicated.
For T1-mapping to successfully translate into clinical
practice, its ability to provide information on the entire
left ventricle in all territories would be important, espe-
cially for a disease such as myocarditis in which path-
ology may be patchy and global. Immediate visual color
T1-maps and those based on validated thresholds to de-
tect disease with minimal extra post-processing steps
[8,19,20] may facilitate the adoption of T1-mapping into
clinical practice.
Limitations
In line with local and international scientific statements
and guidelines, endomyocardial biopsy is not routine
clinical practice in both hospitals, as it is of low diagnos-
tic yield and sensitivity for most cases of myocarditis
with inherent procedural risks [21-27]; as such, direct
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available. As most of the patients (93%) had a preceding
viral or inflammatory illness, after exclusion of obstructive
coronary disease and alternate diagnoses (e.g. Takotsubo,
HCM, DCM, MI) together with their CMR findings, acute
myocarditis is the most likely diagnosis for the majority of
the cohort. The study protocol did not include early gado-
linium enhancement (EGE) for practical reasons, as our
protocol was already lengthy due to whole-heart tissue
characterization for multiple sequences. Thus, we did not
test the ability of T1-mapping to replace EGE imaging.
The original aim of the study was to validate the novel
T1-mapping technique in a selected cohort with suspected
myocarditis defined by clinical features, so none of the
Lake Louise (LL) criteria was used as inclusion criteria. It
has also recently been shown that the sensitivity of “T2
and/or LGE” was significantly higher than the LL criteria
(91% vs 80%), and omission of EGE did not alter the over-
all diagnostic accuracy [28]. For Group III (edema-, LGE-)
patients, while T1-mapping did detect small areas of in-
jury, it is difficult to ascertain the exact etiology of those
findings, especially in patients without a viral prodrome;
causes may include a ruptured coronary plaque or other
causes of myocardial injury. Increased native T1 values
may be seen in a variety of cardiac conditions [29-36] and
it would be important for future studies to test the ability
of native T1-mapping to distinguish different pathologies
systematically in larger clinical studies. T1-thresholds
(such as T1 ≥ 990 ms [8]) for distinguishing disease from
normal may be platform-specific [37]. Further, the incre-
mental T1 thresholds presented in Figure 5 were selected
for illustrative purposes and not directly validated against
severity of tissue injury, although these areas corresponded
to areas of LGE; whether the degree of T1 elevation dir-
ectly corresponds to the severity of injury on the histo-
pathologic level will have to be explored in future studies.
MOLLI-based T1-mapping techniques exhibit some re-
gional variation of T1 values across the myocardium
[11,38]; for the detection of subtle, localized changes, com-
parison to regional T1 norms may further improve the
ability of disease detection.
Conclusions
Native T1-mapping can display the typical non-ischemic
patterns in acute myocarditis, similar to LGE imaging
without the need for contrast agents. T1-mapping also de-
tected additional areas of myocardial involvement and
identified extra cases beyond T2W and LGE imaging, im-
proving the diagnostic confidence when conventional
methods failed to identify abnormalities. In the future, it
may be possible to perform gadolinium-free CMR using
cine and T1-mapping for tissue characterization and may
be particularly useful for patients in whom gadolinium
contrast is contraindicated.Additional file
Additional file 1: CMR Image acquisition parameters.
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